Pliant Therapeutics Statistics

Total Valuation

PLRX has a market cap or net worth of $98.53 million. The enterprise value is -$99.36 million.

Market Cap	98.53M
Enterprise Value	-99.36M

Important Dates

The last earnings date was Thursday, August 7, 2025, after market close.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

PLRX has 61.39 million shares outstanding. The number of shares has increased by 1.67% in one year.

Current Share Class	61.39M
Shares Outstanding	61.39M
Shares Change (YoY)	+1.67%
Shares Change (QoQ)	+0.27%
Owned by Insiders (%)	3.04%
Owned by Institutions (%)	82.05%
Float	54.12M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.47
P/TBV Ratio	0.47
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.99, with a Debt / Equity ratio of 0.27.

Current Ratio	12.99
Quick Ratio	12.84
Debt / Equity	0.27
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-66.24

Financial Efficiency

Return on equity (ROE) is -67.55% and return on invested capital (ROIC) is -37.47%.

Return on Equity (ROE)	-67.55%
Return on Assets (ROA)	-35.07%
Return on Invested Capital (ROIC)	-37.47%
Return on Capital Employed (ROCE)	-78.74%
Revenue Per Employee	n/a
Profits Per Employee	-$1.21M
Employee Count	171
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -86.41% in the last 52 weeks. The beta is 1.43, so PLRX's price volatility has been higher than the market average.

Beta (5Y)	1.43
52-Week Price Change	-86.41%
50-Day Moving Average	1.46
200-Day Moving Average	5.76
Relative Strength Index (RSI)	54.43
Average Volume (20 Days)	1,104,610

Short Selling Information

The latest short interest is 3.28 million, so 5.34% of the outstanding shares have been sold short.

Short Interest	3.28M
Short Previous Month	2.88M
Short % of Shares Out	5.34%
Short % of Float	6.05%
Short Ratio (days to cover)	2.60

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-219.86M
Pretax Income	n/a
Net Income	-206.96M
EBITDA	-217.98M
EBIT	-219.86M
Earnings Per Share (EPS)	-$3.39

Full Income Statement

Balance Sheet

The company has $262.87 million in cash and $60.38 million in debt, giving a net cash position of $202.50 million or $3.30 per share.

Cash & Cash Equivalents	262.87M
Total Debt	60.38M
Net Cash	202.50M
Net Cash Per Share	$3.30
Equity (Book Value)	220.08M
Book Value Per Share	3.59
Working Capital	246.85M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$169.40 million and capital expenditures -$1.48 million, giving a free cash flow of -$170.88 million.

Operating Cash Flow	-169.40M
Capital Expenditures	-1.48M
Free Cash Flow	-170.88M
FCF Per Share	-$2.78

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PLRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.67%
Shareholder Yield	-1.67%
Earnings Yield	-200.68%
FCF Yield	-165.69%

Analyst Forecast

The average price target for PLRX is $3.93, which is 144.86% higher than the current price. The consensus rating is "Hold".

Price Target	$3.93
Price Target Difference	144.86%
Analyst Consensus	Hold
Analyst Count	10
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1